-
Mesothelioma Victim Blames Movie Equipment for Asbestos Exposure
When a person is diagnosed with malignant mesothelioma or any other asbestos-related disease, one of the first things they do is try to figure out how they got sick: where did their asbestos exposure come from. In the case of Christine Slonim, the answer to that question remained a mystery until she and her husband
-
Baylor Mesothelioma Center Adds Take-Home Tumor Treating Fields Device to Treatment
In a nod to their hopes for the new FDA-approved medical device, physicians from Baylor College of Medicine and Baylor St. Luke’s Medical Center are sending mesothelioma patients home with the NovoTTF-110L. The device is the first mesothelioma treatment that the U.S. Food and Drug Administration has approved in more than fifteen years.
-
New Jersey Jury’s $186 Million Mesothelioma Award Driven By CEO Testimony
The New Jersey jury that punished Johnson & Johnson with a $186 million mesothelioma punitive damages decision was likely swayed by testimony from the company’s CEO, Alex Gorsky. In that testimony, the company head appeared out of the loop with reference to the safety of the company’s talc-based products, despite his remarkable level of compensation.
-
Biopharmaceutical Company Partners With Memorial Sloan Kettering for Mesothelioma Test
A clinical biopharmaceutical company has announced that it is partnering with Memorial Sloan Kettering Cancer Center on a new clinical study looking at the impact of its drug in the treatment of malignant pleural mesothelioma. The company, SELLAS Life Sciences Group, focuses on novel cancer immunotherapies, and the test will look at combining its immunotherapeutic
-
Study of Women With Mesothelioma Reveals Valuable Information About Exposures
A study of 354 women diagnosed with malignant mesothelioma has revealed valuable information about the differences in how the disease manifests in women compared with men, as well as about how the majority of women are exposed to the asbestos that caused their disease.
-
Mesothelioma Victims Win $750 Million Punitive Damages Battle Against Johnson & Johnson
A New Jersey jury awarded several mesothelioma victims a $750 million punitive damages award, agreeing with their assertion that Johnson & Johnson’s had been reckless in allowing asbestos to contaminate their talc-based baby powder product. The victims have already won a $37.3 million compensatory damages verdict. The award is a powerful message of punishment to
-
Promising New Chemotherapy Protocol for Unresectable Peritoneal Mesothelioma
When a patient is diagnosed with peritoneal mesothelioma, they’re generally given a better prognosis than those diagnosed with pleural mesothelioma. Peritoneal mesothelioma impacts the abdominal cavity rather than the thoracic cavity that holds the lungs, and generally responds best to a combination of surgery and heated chemotherapy poured directly into the surgical cavity. The exception
-
Italian Study Finds No Decline in Incidence of Mesothelioma
Nearly thirty years after the Italian government took action to ban the use of asbestos, researchers from the University of Pavia have determined that – as of yet – the ban has had no impact on the incidence of malignant mesothelioma.
-
Mesothelioma Lawsuits Against Talc Companies Continue
More than 15,000 lawsuits have been filed against cosmetic talc companies, talc suppliers and others that have been accused of causing consumers’ malignant mesothelioma and other asbestos-related diseases by exposing them to asbestos. The companies continue to argue against their liability, denying that their talc was contaminated by the carcinogen, and courts continue to allow
-
UK Agency Urges Asbestos Training to Protect Against Mesothelioma
The United Kingdom has been hard hit by malignant mesothelioma, the rare and fatal form of cancer cause by exposure to asbestos. The nation has a significant amount of buildings that are contaminated with the carcinogenic material, and as a result tradesmen and women continue to be put at risk, despite the fact that the
-
Roofer’s Widow Defeats Asbestos Company’s Bid to Escape Mesothelioma Lawsuit
Despite asbestos being an acknowledged carcinogen, companies whose products contain the toxic material continue to fight lawsuits filed by mesothelioma victims and others they’ve injured. Their primary method of argument is to deny both that asbestos victims actually used their product, and that the asbestos in their products was the proximate cause of their illness.
-
Israeli Blood Test Could Confirm Mesothelioma in Hours
An Israeli company has developed a new type of liquid biopsy that could confirm a diagnosis of malignant mesothelioma in a matter of hours. Much of the challenge of treating mesothelioma lies in the fact that it is most often diagnosed when it is very far advanced, and the promise of a fast and simple blood
-
Study Suggests Low-Dose CT Screening For Those At Risk for Mesothelioma
Construction workers, factory and shipyard workers, veterans and untold numbers of others are at risk for malignant mesothelioma as a result of having been exposed to asbestos. Because the rare and deadly form of cancer has such a long latency period, these men and women are forced to live with a cloud of anxiety, worrying
-
Barber Seeks Justice After His Wife Dies of Malignant Mesothelioma
A lawsuit currently making its way through the New York City Asbestos Litigation courts is pitting a man and his daughter against the companies that they say caused their wife and mother to die of malignant mesothelioma. The man, Eddie Germain, had spent decades working as a barber, and he and his daughter Mildred are
-
Initial Results from Mesothelioma Clinical Trial Show Unexpectedly Positive Results
A press release issued by the immune-oncology company Targovax ASA is inspiring hope in patients diagnosed with malignant mesothelioma. The company revealed that initial clinical results of combining their ONCOS-102 cancer virus with standard chemotherapy provided patients with significantly improved progression-free survival and disease control.
-
One-Sentence Notice from Pennsylvania Supreme Court Permits Mesothelioma Case to Continue
It has been almost five years since Leon Franklin Lamson, Jr. died of malignant mesothelioma, but his family has continued fighting for justice on his behalf, and this week they won a significant decision when the Pennsylvania Supreme Court rejected the arguments made by asbestos companies and refused to disturb an earlier court decision allowing
-
Mesothelioma Fears Drive $25 Million Asbestos Lawsuit Against City of San Diego
A contract engineer has filed a $25 million lawsuit against the city of San Diego, accusing his former employer of knowingly exposing hundreds of workers to the risk of malignant mesothelioma and other diseases and lying about the presence of asbestos in a leased high rise that it was remodeling.
-
Mesothelioma Victim’s Case Against General Electric Allowed to Continue
When Fidel Rivera’s began working as an electrician’s apprentice at the age of 18, he never dreamed that it would lead to a fatal diagnosis of malignant pleural mesothelioma. He died soon after that diagnosis, but not before he could file a lawsuit against General Electric, the company that manufactured the asbestos-contaminated products that caused
-
UK Mesothelioma Care Relies Heavily On Clinical Nurse Specialists
The United Kingdom has the highest incidence of malignant mesothelioma in the world, with roughly 2,700 people diagnosed with the rare and fatal form of the disease every year. In response to the overwhelming rate of illnesses arising from exposure to asbestos, the nation has established a treatment program that relies heavily on a network
-
Australian Study Confirms Survival Success of Combined Treatment for Peritoneal Mesothelioma
Though malignant mesothelioma is known to be a terminal illness, a recently completed Australian study has provided an optimistic conclusion for those diagnosed with the peritoneal form of the disease. According to a study of more than 1,200 patients who had both cytoreductive surgery and intraperitoneal chemotherapy, the combination of the two protocols provides long-term
